ATE293254T1 - Modulierung von mlk- (multiple lineage kinase) proteinen - Google Patents
Modulierung von mlk- (multiple lineage kinase) proteinenInfo
- Publication number
- ATE293254T1 ATE293254T1 AT99943759T AT99943759T ATE293254T1 AT E293254 T1 ATE293254 T1 AT E293254T1 AT 99943759 T AT99943759 T AT 99943759T AT 99943759 T AT99943759 T AT 99943759T AT E293254 T1 ATE293254 T1 AT E293254T1
- Authority
- AT
- Austria
- Prior art keywords
- lineage kinase
- multiple lineage
- methods
- compound
- protein
- Prior art date
Links
- 108091000080 Phosphotransferase Proteins 0.000 title 1
- 102000020233 phosphotransferase Human genes 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- G01N2333/91205—Phosphotransferases in general
- G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Pathology (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Cell Biology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9798098P | 1998-08-26 | 1998-08-26 | |
| PCT/US1999/018864 WO2000013015A1 (en) | 1998-08-26 | 1999-08-18 | Modulating multiple lineage kinase proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE293254T1 true ATE293254T1 (de) | 2005-04-15 |
Family
ID=22266038
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99943759T ATE293254T1 (de) | 1998-08-26 | 1999-08-18 | Modulierung von mlk- (multiple lineage kinase) proteinen |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1105728B1 (de) |
| JP (1) | JP2002523780A (de) |
| KR (1) | KR100700028B1 (de) |
| CN (3) | CN1879617A (de) |
| AT (1) | ATE293254T1 (de) |
| AU (1) | AU765637B2 (de) |
| BG (1) | BG105360A (de) |
| BR (1) | BR9913190A (de) |
| CA (1) | CA2339539A1 (de) |
| CZ (1) | CZ2001701A3 (de) |
| DE (1) | DE69924738T2 (de) |
| DK (1) | DK1105728T3 (de) |
| EA (2) | EA006648B1 (de) |
| ES (1) | ES2241316T3 (de) |
| HU (1) | HUP0103079A3 (de) |
| NO (1) | NO20010389L (de) |
| NZ (1) | NZ509612A (de) |
| PL (1) | PL346246A1 (de) |
| PT (1) | PT1105728E (de) |
| SK (1) | SK2542001A3 (de) |
| TR (2) | TR200400635T2 (de) |
| UA (1) | UA74772C2 (de) |
| WO (1) | WO2000013015A1 (de) |
| ZA (1) | ZA200100835B (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6811992B1 (en) | 1998-05-14 | 2004-11-02 | Ya Fang Liu | Method for identifying MLK inhibitors for the treatment of neurological conditions |
| US6841567B1 (en) | 1999-02-12 | 2005-01-11 | Cephalon, Inc. | Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| US7122679B2 (en) * | 2000-05-09 | 2006-10-17 | Cephalon, Inc. | Multicyclic compounds and the use thereof |
| BR0113266A (pt) * | 2000-08-11 | 2005-01-04 | Cephalon Inc | Métodos para modular proteìnas quinase de linhagem múltipla e compostos protetores que modulam proteìnas quinase de linhagem múltipla |
| US7018999B2 (en) | 2001-05-16 | 2006-03-28 | Cephalon, Inc. | Methods for the treatment and prevention of pain |
| FR2826653B1 (fr) * | 2001-06-29 | 2005-10-14 | Servier Lab | Nouveaux derives de pyrido-pyrido-pyrrolo[3,2-g]pyrrolo [3,4-e]-indole et pyrido-pyrrolo[2,3-a]pyrrolo[3,4-c] carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| JP2003052395A (ja) * | 2001-08-09 | 2003-02-25 | Japan Tissue Engineering:Kk | 移植適正判定方法 |
| TWI468417B (zh) | 2007-11-30 | 2015-01-11 | Genentech Inc | 抗-vegf抗體 |
| CA2711585A1 (en) * | 2008-02-04 | 2009-08-13 | Galapagos Nv | Molecular targets and compounds, and methods to identify the same, useful in the treatment of neurodegenerative diseases |
| US20100056609A1 (en) * | 2008-08-26 | 2010-03-04 | Washington University | Methods and compositions for inhibition of axonal degeneration by modulation of the dlk/jnk pathway |
| CA2741089A1 (en) | 2008-10-22 | 2010-04-29 | Genentech, Inc. | Modulation of axon degeneration |
| AU2015202365B2 (en) * | 2008-10-22 | 2016-11-24 | Genentech, Inc. | Modulation of axon degeneration |
| SG10201406763WA (en) * | 2009-10-22 | 2014-11-27 | Genentech Inc | Modulation of axon degeneration |
| ES2385157B1 (es) * | 2010-02-25 | 2013-07-08 | Universidad Del País Vasco | Compuestos para el tratamiento de alzheimer. |
| EP2852388A4 (de) * | 2012-05-23 | 2016-01-13 | Univ Johns Hopkins | Verbindungen und verfahren zur verwendung davon zur behandlung von neurodegenerativen erkrankungen |
| CN109060472A (zh) * | 2018-07-20 | 2018-12-21 | 上海市农业科学院 | 一种适于荧光染色的草菇菌褶组织切片的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5756494A (en) * | 1992-07-24 | 1998-05-26 | Cephalon, Inc. | Protein kinase inhibitors for treatment of neurological disorders |
| US5705511A (en) * | 1994-10-14 | 1998-01-06 | Cephalon, Inc. | Fused pyrrolocarbazoles |
| US5475110A (en) * | 1994-10-14 | 1995-12-12 | Cephalon, Inc. | Fused Pyrrolocarbazoles |
| US6811992B1 (en) * | 1998-05-14 | 2004-11-02 | Ya Fang Liu | Method for identifying MLK inhibitors for the treatment of neurological conditions |
-
1999
- 1999-08-18 SK SK254-2001A patent/SK2542001A3/sk unknown
- 1999-08-18 WO PCT/US1999/018864 patent/WO2000013015A1/en not_active Ceased
- 1999-08-18 EP EP99943759A patent/EP1105728B1/de not_active Expired - Lifetime
- 1999-08-18 EA EA200100278A patent/EA006648B1/ru not_active IP Right Cessation
- 1999-08-18 HU HU0103079A patent/HUP0103079A3/hu unknown
- 1999-08-18 ES ES99943759T patent/ES2241316T3/es not_active Expired - Lifetime
- 1999-08-18 BR BR9913190-0A patent/BR9913190A/pt not_active Application Discontinuation
- 1999-08-18 CZ CZ2001701A patent/CZ2001701A3/cs unknown
- 1999-08-18 DK DK99943759T patent/DK1105728T3/da active
- 1999-08-18 KR KR1020017002385A patent/KR100700028B1/ko not_active Expired - Fee Related
- 1999-08-18 CN CNA200610099703XA patent/CN1879617A/zh active Pending
- 1999-08-18 CN CNB998101354A patent/CN1206535C/zh not_active Expired - Fee Related
- 1999-08-18 TR TR2004/00635T patent/TR200400635T2/xx unknown
- 1999-08-18 AT AT99943759T patent/ATE293254T1/de active
- 1999-08-18 AU AU56793/99A patent/AU765637B2/en not_active Ceased
- 1999-08-18 DE DE69924738T patent/DE69924738T2/de not_active Expired - Lifetime
- 1999-08-18 PT PT99943759T patent/PT1105728E/pt unknown
- 1999-08-18 UA UA2001031963A patent/UA74772C2/uk unknown
- 1999-08-18 PL PL99346246A patent/PL346246A1/xx not_active Application Discontinuation
- 1999-08-18 EA EA200500934A patent/EA200500934A1/ru unknown
- 1999-08-18 NZ NZ509612A patent/NZ509612A/en not_active IP Right Cessation
- 1999-08-18 CA CA002339539A patent/CA2339539A1/en not_active Abandoned
- 1999-08-18 TR TR2001/00589T patent/TR200100589T2/xx unknown
- 1999-08-18 JP JP2000567949A patent/JP2002523780A/ja active Pending
- 1999-08-18 CN CNA2004100491086A patent/CN1589788A/zh active Pending
-
2001
- 2001-01-23 NO NO20010389A patent/NO20010389L/no not_active Application Discontinuation
- 2001-01-30 ZA ZA2001/00835A patent/ZA200100835B/en unknown
- 2001-03-19 BG BG105360A patent/BG105360A/bg unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69924738D1 (de) | Modulierung von mlk- (multiple lineage kinase) proteinen | |
| DK0804163T3 (da) | Forbedret fremgangsmåde til stabilisering af biologiske stoffer under tørring og efterfølgende opbevaring samt præparater deraf | |
| DE60237917D1 (de) | Gfats als modifikatoren des p53-wegs und verwendungsverfahren | |
| ATE391177T1 (de) | Zusammensetzungen und methoden zur modulierung der zellulären aktivität von nf-kappab | |
| WO2003079020A3 (en) | Methods and compositions for the identification, assessment, and therapy of small cell lung cancer | |
| ATE499445T1 (de) | Menschliche ubiqutin ligase e3. verwendung für die modulation von nf-kappa b | |
| DE69940980D1 (de) | Rana pipiens proteine und deren verwendung in der behandlung von tumoren | |
| PT862622E (pt) | Metodo de rastreio para compostos que interagem com proteina cinase rac | |
| WO2000026245A3 (en) | Human membrane transport proteins | |
| WO2000017355A3 (en) | Human cytoskeleton associated proteins | |
| ATE301192T1 (de) | Verwendung von neuronalem apoptose- inhibitorprotein | |
| WO2002054066A3 (en) | Non-apoptotic forms of cell death and methods of modulation | |
| WO2002014536A3 (en) | Odulating multiple lineage kinase proteins | |
| WO2004109290A3 (en) | Methods for identifying modulators of kinesin activity | |
| DK1082415T3 (da) | Anvendelige fremgangsmåder til modulation af angioge-nese ved anvendelse af tyrosin kinase SRC | |
| WO1999031128A3 (en) | Human tumor necrosis factor-r2-like proteins | |
| WO1999041373A3 (en) | Human transport-associated molecules | |
| DE60007864D1 (de) | Verwendung von antileukoprotease zur behandlung von endometriose | |
| DE69738945D1 (de) | Rken | |
| DE69825307D1 (de) | Verwendung von protein h als zytostattischer wirkstoff | |
| WO2001020335A3 (en) | Methods for modulating cell proliferation | |
| ATE272406T1 (de) | Prognose von ptp lar vermittelten krankheiten | |
| WO1999019482A3 (en) | Vesicle transport associated proteins | |
| MX9710291A (es) | Inhibidores ligantes de proteinas de fijacion con factor de crecimiento del tipo de insulina y metodos de uso para los mismos. | |
| WO2000000510A3 (en) | Growth factor modulators |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1105728 Country of ref document: EP |